24 June 2026
Vulcan Two Group plc
(the "Company", "Group" or "Vulcan Two")
Result of Annual General Meeting
The Annual General Meeting of Vulcan Two Group plc was held at the offices of Canaccord Genuity Limited, 88 Wood Street, London EC2V 7QR earlier today.
All 13 resolutions put to members were passed on a poll. Resolutions 1 to 10 were passed as ordinary resolutions and resolutions 11 to 13 were passed as special resolutions.
The voting results will shortly be available on the Company's website at: www.vulcantwo.com
For further information please contact:
|
Vulcan Two Group plc Michael Kraftman, Chief Executive Officer Keith Butcher, Chief Finance Officer Brendan O'Brien, Chief Operating Officer |
Email: info@vulcantwo.com |
|
Canaccord Genuity Limited Simon Bridges / Harry Pardoe / Elizabeth Halley-Stott |
Tel: +44 (0) 20 7523 8000 |
|
Alma Strategic Communications Justine James / Sam Modlin / Will Merison |
Email: vulcantwo@almastrategic.com Tel: +44 (0) 20 3405 0205 |
Notes to Editors
Vulcan Two Group plc (AIM:VUL) is creating the UK's leading regulated ePharmacy platform, through its disciplined buy-and-build strategy. Following the acquisitions of CloudRx, Webmed and Hyperdrug in March 2026, the Group has established a diversified, profitable platform spanning B2B prescription fulfilment and B2C digital pharmacy services, with a high proportion of recurring revenues and strong cash generation. Future growth is expected to be supported through the acquisition of complementary businesses, expansion into new sectors or markets, and investment in long-term assets.
The Group is led by an experienced management team with deep healthcare, eCommerce and buy-and-build expertise.
For more information, visit www.vulcantwo.com